m6A-mediated silencing of RNF41 by METTL3/YTHDC1 disrupts autophagy to drive intervertebral disc degeneration
Open Access
- 3 November 2025
- journal article
- research article
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 41 (1) , 1-18
Abstract
Background Intervertebral disc (IVD) degeneration (IDD) represents a predominant origin of low back pain and disability, yet current therapeutic interventions remain suboptimal. Emerging evidence highlights autophagy activation as a therapeutic strategy against IDD. This study investigates the mechanistic interplay between N6-methyladenosine (m6A) modifications and autophagy dysregulation in IDD pathogenesis. Methods Bioinformatics analysis identified ring finger protein 41 (RNF41) as a key autophagy-IDD intersection gene. Functional validation utilized tert-butyl hydroperoxide (TBHP)-treated human nucleus pulposus (NP) cells to assess RNF41’s effects on senescence (CDKN2A), autophagy (LC3-II/p62), apoptosis (TUNEL), inflammation (IL-18/IL-1β), and extracellular matrix (ECM) homeostasis (aggrecan/MMP). Key m6A regulators modulating autophagy were screened via correlation analysis. In vivo validation employed adeno-associated virus (AAV)-mediated methyltransferase-like 3 (METTL3)/RNF41 delivery in puncture-induced IDD rat models. Results RNF41 expression was downregulated in human IVD tissues. Overexpression of RNF41 mitigated TBHP-induced senescence, apoptosis, activated AMPK/mTOR-mediated autophagy, suppressed inflammation, and restored ECM balance. The autophagy inhibitor chloroquine (CQ) abolished the protective effects of RNF41 overexpression on degenerative NP cells. Mechanistically, METTL3/YTHDC1 co-regulation in degenerative NP cells mediated m6A hypermethylation of RNF41 mRNA, shortening its half-life via YTHDC1-dependent decay. Intradiscal METTL3-silencing AAV attenuated puncture-induced disc loss and histopathological degeneration, whereas RNF41-silencing AVV exacerbated ECM disruption and annular disorganization. Conclusion METTL3/YTHDC1-mediated m6A modification drives IDD progression by silencing RNF41, thereby impairing autophagy and ECM integrity. Targeting this axis offers a clinically actionable strategy to delay disc degeneration, particularly in patients with early-stage IDD. This evidence establishes RNF41’s role as a theragnostic biomarker and therapeutic targe, enabling precision-guided interventional approaches.Keywords
Funding Information
- 2019 Medical Service and Support Capability Improvement Subsidy Fund (2019-57)
This publication has 48 references indexed in Scilit:
- Isorhapontigenin delays senescence and matrix degradation of nucleus pulposus cells via PI3K/AKT/mTOR-mediated autophagy pathway in vitro and alleviates intervertebral disc degeneration in vivoInternational Immunopharmacology, 2024
- Low selenium and T-2 toxin may be involved in the pathogenesis of Kashin-Beck disease by affecting AMPK/mTOR/ULK1 pathway mediated autophagyEcotoxicology and Environmental Safety, 2024
- The role of oxidative stress in intervertebral disc degeneration: Mechanisms and therapeutic implicationsAgeing Research Reviews, 2024
- Pseudolaric acid B suppresses NSCLC progression through the ROS/AMPK/mTOR/autophagy signalling pathwayBiomedicine & Pharmacotherapy, 2024
- M6A methylation‐regulated autophagy may be a new therapeutic target for intervertebral disc degenerationCell Biology International, 2024
- Impact of autophagy inhibition on intervertebral disc cells and extracellular matrixJOR SPINE, 2023
- Epigenetic modifications of inflammation in intervertebral disc degenerationAgeing Research Reviews, 2023
- m6A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiencyClinical and Translational Medicine, 2022
- Cartilage endplate stem cells inhibit intervertebral disc degeneration by releasing exosomes to nucleus pulposus cells to activate Akt/autophagyStem Cells, 2021
- Targeting autophagy-related protein kinases for potential therapeutic purposeActa Pharmaceutica Sinica B, 2020